Jpmorgan Chase & CO Avita Medical, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RCEL
# of Institutions
72Shares Held
6.22MCall Options Held
11.6KPut Options Held
40.1K-
Black Rock Inc. New York, NY1.78MShares$19.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$15.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA586KShares$6.55 Million0.0% of portfolio
-
State Street Corp Boston, MA508KShares$5.67 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT267KShares$2.98 Million0.21% of portfolio
About AVITA Medical, Inc.
- Ticker RCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,030,900
- Market Cap $280M
- Description
- AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...